Valued at Rs 6305 crores, with 10 therapies and 12 regions exceeding market growth rate The Indian pharma market (IPM) is valued at Rs 6,305... ...http://pharma.financialexpress.com/sections/market-section/3044-ipm-de-grew-1-7-per-cent-in-october-2013
While market-based pricing can potentially reduce pricing for two-third essential medicines, there are far too many loopholes to reduce your... ...http://moneylife.in/article/dpco-2013-loopholes-oppi-view-and-moneylife-counterview-ndash-part2/35504.html
Biocon Ltd, India's largest publicly-held biotechnology company, announced today that it has received marketing authorisation from the Drugs... ...http://www.business-standard.com/article/companies/biocon-mylan-set-to-debut-its-biosimilar-breast-cancer-drug-113112600481_1.html
Industry : Healthcare Category : Mergers & Acquisitions Ranbaxy Laboratoriesis close to make an exit from its Bangalore-based vaccine... ...http://www.dealcurry.com/20131125-Ranbaxy-To-Exit-Vaccine-Business-Biovel.htm
While market based pricing can potentially reduce rates for two-third essential medicines, there are far too many loopholes in the move. Pharma... ...http://moneylife.in/article/medicine-prices-dpco-loopholes-will-deny-cheaper-essential-drugsndashpart2/35249.html
Meher Pharma International provides...